
Almost 300,000 women are to be offered a drug to reduce their risk of developing breast cancer, the NHS has announced.
Scientists have found that the hormone therapy - called anastrozole - can prevent women from developing breast cancer and that the protective effect lasts for years after a woman has stopped taking the drug.